PERSISTENT DYSKINESIA AFTER LONG-TERM TREATMENT WITH NEUROLEPTICS IN JAPAN:ITS PRESENT STATUS AND CLINICAL PROBLEMS

スポンサーリンク

概要

• 論文の詳細を見る

• The studies on drug-induced persistent dyskinesia in Japan began only in the late nineteen-sixties, while the first historical description of the symptom by French authors was published in 1959. Then, at first, the literatures re-ported by Japanese workers were briefly reviewed and the prevalences, char-acteristics of the patients and correlations between the manifestation of the symptoms and characteristics of psychotropic drugs were summarized.Secondly, two clinically important problems were discussed from the findings of 19 dyskinetic patients in Minakawa Mental Hospital. The first problem was concerned with the reversibility of persistent dyskinesia and the second with the relationship between persistent dyskinesia and other types of extrapyramidal reactions.In conclusion, it was stressed that the earlier diagnosis and earlier re-moval of the drug were important for the prophylaxis of irreversible persistent dyskinesia and that close relationship of persistent dyskinesia with the other types of extrapyramidal reaction (acute dyskinesia, akathisia and parkin-sonism) should be taken into consideration for the prediction of the symptom.

• The Keio Journal of Medicineの論文

著者

• Miura Sadanori

  Department Of Psychiatry

• Ohtsuka Nobuo

  Department Of Physics Osaka University

• Yagi Gohei

  Department Of Neuropsychiatry Keio University School Of Medicine

• Itoh Hitoshi

  Department Of Pathology School Of Medicine Tokai University

• OGITA KAZUHIRO

  Department of Neuropsychiatry, School of Medicine, Keio University

• OHTSUKA NOBUO

  Department of Neuropsychiatry, School of Medicine, Keio University

• ITOH HITOSHI

  Department of Neuropsychiatry, School of Medicine, Keio University

• MIURA SADANORI

  Department of Neuropsychiatry, School of Medicine, Kitasato University

関連論文

• Photic Stimulation of Intracellular cAMP-Dependent Protein Kinase in Paramecium
• Prognostic Factors for Node-Negative Breast Cancers: Results of a Study Program by the Japanese Breast Cancer Society
• Effectiveness of herbal medicine (Rokumigan and Hachimijiogan) for fatigue or loss of energy in patients with partial remitted major depressive disorder
• Clinical efficacy of tandospirone augmentation in patients with major depressive disorder : A randomized controlled trial
• Herbal medicine in the treatment of fluvoxamine-induced nausea and dyspepsia
• Effectiveness of nilvadipine in two cases of chronic schizophrenia
• Current topics in tardive dyskinesia in Japan
• Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia : Results of the Japan multicenter, double-blind olanzapine trial
• A transcultural study of psychopharmacotherapy for schizophrenia of neuroleptic treatment between Tokyo and Bali
• 66. Electrophoretic changes of lipoprotein fractions of cerebrospinal fluid in cases of neurological diseases.
• A survey on the drug therapy for delirium
• Immunological Properties of Dopamine-β-hydroxylase of Human Cerebrospinal Fluid
• Efficacy and safety of olanzapine, an atypical antipsychotic, in patients with schizophrenia : Results of an open-label multicenter study in Japan
• THERAPEUTIC APPLICATION OF HISTOCHEMISTRY TO BREAST CANCERS : Trastuzumab treatment and selection of patients based on HER2 histochemistry
• Pathological Evaluation of HER2 Overexpression : For the Treatment of Metastatic Breast Cancers by Humanized Anti-HER2 Monoclonal Antibody (Trastuzumab)
• Quantitative immunohistochemical evaluation of HER2/neu expression with Hercep Test^ in breast carcinoma by image analysis
• Longitudinal Polarizations of Emitted Neutron in Muon Capture on ^Ca
• Attitude of Patients with Schizophrenia toward Neuroleptics in Japan
• A 10-year follow-up study of tardive dyskinesia. With special reference to the influence of neuroleptic administration on the long-term prognosis.:WITH SPECIAL REFERENCE TO THE INFLUENCE OF NEUROLEPTIC ADMINISTRATION ON THE LONG-TERM PROGNOSIS
• Clinical study on the psychotropic effects of caerulein. An open clinical trial in chronic schizophrenic patients.:AN OPEN CLINICAL TRIAL IN CHRONIC SCHIZOPHRENIC PATIENTS
• Dexamethasone suppression test in affective and other psychiatric disorders.
• PERSISTENT DYSKINESIA AFTER LONG-TERM TREATMENT WITH NEUROLEPTICS IN JAPAN:ITS PRESENT STATUS AND CLINICAL PROBLEMS
• Nuclear design of heliotron fusion reactor blankets.

もっと見る 閉じる

スポンサーリンク